Lessee, Operating Lease, Liability, to be Paid in USD of ABVC BIOPHARMA, INC. from Q2 2023 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease.
Summary
Abvc Biopharma, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid history and change rate from Q2 2023 to Q3 2025.
  • Abvc Biopharma, Inc. Lessee, Operating Lease, Liability, to be Paid for the quarter ending September 30, 2025 was $378K, a 25.6% decline year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, YoY Quarterly Change (%)

ABVC BIOPHARMA, INC. Quarterly Lessee, Operating Lease, Liability, to be Paid (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $378K -$130K -25.6% Sep 30, 2025 10-Q 2025-11-03
Q2 2025 $473K -$136K -22.3% Jun 30, 2025 10-Q 2025-08-13
Q1 2025 $547K -$164K -23% Mar 31, 2025 10-Q 2025-04-30
Q4 2024 $656K -$157K -19.3% Dec 31, 2024 10-K 2025-04-15
Q3 2024 $509K -$396K -43.7% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $609K -$397K -39.5% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $711K Mar 31, 2024 10-Q 2024-05-17
Q4 2023 $813K Dec 31, 2023 10-K 2024-03-13
Q3 2023 $905K Sep 30, 2023 10-Q 2023-11-15
Q2 2023 $1.01M Jun 30, 2023 10-Q 2023-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.